Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125932462 | 12593246 | 2 | F | 20140519 | 20160819 | 20160726 | 20160826 | EXP | GB-JNJFOC-20160718985 | JANSSEN | 62.94 | YR | A | F | Y | 98.00000 | KG | 20160826 | CN | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125932462 | 12593246 | 1 | PS | STELARA | USTEKINUMAB | 1 | Subcutaneous | ON WEEK 16 AS DIRECTED | N | UNKNOWN | 125261 | 45 | MG | SOLUTION FOR INJECTION | |||||
| 125932462 | 12593246 | 2 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 125932462 | 12593246 | 3 | C | VENLAFAXINE | VENLAFAXINE HYDROCHLORIDE | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 125932462 | 12593246 | 4 | C | CALCICHEW D3 | CALCIUMCHOLECALCIFEROL | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 125932462 | 12593246 | 5 | C | CODEINE | CODEINE | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 125932462 | 12593246 | 6 | C | SALBUTAMOL | ALBUTEROL | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 125932462 | 12593246 | 7 | C | GAVISCON | ALUMINUM HYDROXIDEMAGNESIUM CARBONATE | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 125932462 | 12593246 | 8 | C | AMITRIPTYLINE | AMITRIPTYLINE | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 125932462 | 12593246 | 9 | C | ARCOXIA | ETORICOXIB | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 125932462 | 12593246 | 10 | C | ASPIRIN. | ASPIRIN | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 125932462 | 12593246 | 11 | C | ATORVASTATIN | ATORVASTATIN | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 125932462 | 12593246 | 12 | C | DOXYCYCLINE. | DOXYCYCLINE | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 125932462 | 12593246 | 13 | C | METRONIDAZOLE. | METRONIDAZOLE | 1 | Unknown | 0 | UNSPECIFIED |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125932462 | 12593246 | 1 | Psoriasis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125932462 | 12593246 | HO |
| 125932462 | 12593246 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125932462 | 12593246 | Clostridium difficile infection | |
| 125932462 | 12593246 | Inappropriate schedule of drug administration | |
| 125932462 | 12593246 | Off label use | |
| 125932462 | 12593246 | Urinary tract infection |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125932462 | 12593246 | 1 | 20140519 | 0 | ||
| 125932462 | 12593246 | 2 | 19980715 | 0 | ||
| 125932462 | 12593246 | 3 | 20020615 | 0 | ||
| 125932462 | 12593246 | 4 | 20050415 | 0 | ||
| 125932462 | 12593246 | 5 | 20070515 | 0 | ||
| 125932462 | 12593246 | 6 | 20070515 | 0 | ||
| 125932462 | 12593246 | 7 | 20110315 | 0 | ||
| 125932462 | 12593246 | 8 | 20110830 | 0 | ||
| 125932462 | 12593246 | 9 | 20120924 | 0 | ||
| 125932462 | 12593246 | 10 | 20131030 | 0 | ||
| 125932462 | 12593246 | 11 | 20131117 | 0 | ||
| 125932462 | 12593246 | 12 | 20160509 | 20160513 | 0 | |
| 125932462 | 12593246 | 13 | 20160515 | 20160521 | 0 |